HTLV-1-associated myelopathy/tropical spastic paraparesis

CRM Bangham, A Araujo, Y Yamano… - Nature reviews Disease …, 2015 - nature.com
Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive disease of the CNS that causes weakness or paralysis of the …

Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis

Y Yamano, T Sato - Frontiers in microbiology, 2012 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1), a human retrovirus, is the causative agent of a
progressive neurological disease termed HTLV-1-associated myelopathy/tropical spastic …

HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment

N Futsch, R Mahieux, H Dutartre - Viruses, 2017 - mdpi.com
Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Inflammatory manifestations of HTLV-1 and their therapeutic options

F Martin, GP Taylor, S Jacobson - Expert review of clinical …, 2014 - Taylor & Francis
Human T lymphotropic virus type 1 (HTLV-1) is one of the most intriguing retroviruses
infecting humans. Most commonly, infection remains undetected, since it does not cause …

[HTML][HTML] An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory …

J Yamauchi, N Araya, N Yagishita, T Sato… - Pharmacology & …, 2021 - Elsevier
Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: a randomized controlled trial (HAMLET-P)

J Yamauchi, K Tanabe, T Sato, M Nakagawa… - Viruses, 2022 - mdpi.com
Corticosteroids are most commonly used to treat HTLV-1-associated myelopathy (HAM);
however, their clinical efficacy has not been tested in randomized clinical trials. This …

Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1 …

MA Demontis, S Hilburn, GP Taylor - AIDS research and human …, 2013 - liebertpub.com
Human T cell lymphotropic virus type 1 (HTLV-1) proviral load (PVL) in peripheral blood
mononuclear cells (PBMCs) is high in patients with adult T cell leukemia/lymphoma or HTLV …

Tremor induced by cyclosporine, tacrolimus, sirolimus, or everolimus: a review of the literature

A Wagle Shukla, C Lunny, O Mahboob, U Khalid… - Drugs in R&D, 2023 - Springer
Calcineurin inhibitors such as cyclosporine and tacrolimus are immunosuppressant drugs
that are known to induce tremors. Non-calcineurin inhibitors such as sirolimus and …

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

A Pasquier, S Alais, L Roux, MI Thoulouze… - Frontiers in …, 2018 - frontiersin.org
Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …

Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net)

ALG Coler-Reilly, N Yagishita, H Suzuki, T Sato… - Orphanet Journal of …, 2016 - Springer
Background At least one million people are infected with human T-lymphotropic virus type 1
(HTLV-1) in Japan, a small percentage of whom develop HTLV-1-associated …